The company has supply agreements with Serum Institute of India (SII) and SLS for the manufacture and supply of antigen drug substance and finished COVID-19 vaccine doses. In May 2024, the company and SLS entered into the SLS Supply Agreement, under which SLS supplies antigen drug substance and finished vaccine doses, while the company provides SLS with all Matrix-M™ adjuvant required for manufacturing. The company produces its proprietary Matrix-M™ adjuvant at its Novavax AB facility in Uppsala, Sweden, and has contract manufacturing arrangements with AGC Biologics and the Polypeptide Group for large-scale production of the adjuvant. Under the SII R21 Agreement, SII purchases Matrix-M™ adjuvant for development and commercial purposes and pays royalties based on vaccine sales. The company primarily relies on the supply agreement with SLS for co-formulation, filling, and finishing of COVID-19 vaccine doses.
Novavax Inc's Comment on Supply Chain
The company has supply agreements with Serum Institute of India (SII) and SLS for the manufacture and supply of antigen drug substance and finished COVID-19 vaccine doses. In May 2024, the company and SLS entered into the SLS Supply Agreement, under which SLS supplies antigen drug substance and finished vaccine doses, while the company provides SLS with all Matrix-M™ adjuvant required for manufacturing. The company produces its proprietary Matrix-M™ adjuvant at its Novavax AB facility in Uppsala, Sweden, and has contract manufacturing arrangements with AGC Biologics and the Polypeptide Group for large-scale production of the adjuvant. Under the SII R21 Agreement, SII purchases Matrix-M™ adjuvant for development and commercial purposes and pays royalties based on vaccine sales. The company primarily relies on the supply agreement with SLS for co-formulation, filling, and finishing of COVID-19 vaccine doses.
Sources:
Novavax inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Novavax inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
